Swiss perspectives in 10 languages

Swiss researchers accidentally enhance effects of Botox

Botox
Botox is used to treat a number of conditions, including stomach cancer. Keystone / Z1004/_peer Grimm

Swiss researchers have stumbled upon the means to supercharge Botox, as they were carrying out experiments designed to dampen the effects of the neurotoxin.

The research project was looking for ways to inhibit the effects of Botox, according to a statement from the Paul Scherrer Institute (PSI) on Monday.

PSI researchers developed proteins that dock onto the part of the enzyme that is responsible for its effect on the nerves. This technique was intended to act as a suppressant.  

To the researchers’ surprise, however, the opposite happened: the toxic effect began even faster than usual, as a report published on Monday in the journal “Nature Communications” showed. “We initially thought we had done something wrong,” study lead author Oneda Leka was quoted as saying in the PSI announcement.

Botulinum toxin A1, or Botox for short, gained notoriety through its use as a cosmetic aid. However, Botox is also used in therapeutic medicine, as the PSI emphasised.

For example, to treat pain, spasticity or bladder weakness. Even in stomach cancer, Botox is used to block the vagus nerve and thus slow tumor growth.

Botox works by breaking down certain proteins that are important for nerve signal transmission. In the research project, the researchers artificially produced small proteins, so-called DARPin, which were intended to function similarly to antibodies and dock to the part of the protein that is responsible for cutting up other proteins.

“In vitro – i.e. in the test tube on individual samples – we have also identified a suitable DARPin candidate that curbs the function of botulinum toxin,” said study leader Richard Kammerer.

However, in experiments in the laboratory and later in mouse muscles, the opposite occurred. The researchers explain this by saying that the DARPin actually destabilises the toxin in such a way that it is transported more quickly into the interior of the nerve cell.

But this is not bad news, the researchers emphasised: Botox, for example, could relieve pain more quickly than before.

This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here

If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.

External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Daily news

Get the most important news from Switzerland in your inbox.

Daily

The SBC Privacy Policy provides additional information on how your data is processed.


Popular Stories

Most Discussed

News

National wants more money for agriculture

More

Swiss parliament approves higher agricultural subsidies

This content was published on Agriculture to benefit from greater federal support between 2026 and 2029. On Wednesday, the National Council increased funding for production and sales promotion and for direct payments by a total of almost 400 million euros.

Read more: Swiss parliament approves higher agricultural subsidies
Gender discrimination should be punishable in Switzerland

More

Swiss senate votes to make gender discrimination punishable by law

This content was published on Incitement to hatred or discrimination on the grounds of gender should be punishable in Switzerland. On Wednesday, the Council of States voted 21-18 in favor of six similar parliamentary initiatives to supplement the penal code.

Read more: Swiss senate votes to make gender discrimination punishable by law

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR